• Je něco špatně v tomto záznamu ?

Communicating computational workflows in a regulatory environment

JG. Keeney, N. Gulzar, JB. Baker, O. Klempir, GD. Hannigan, DA. Bitton, JM. Maritz, CHS. King, JA. Patel, P. Duncan, R. Mazumder

. 2024 ; 29 (3) : 103884. [pub] 20240112

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006917

The volume of nucleic acid sequence data has exploded recently, amplifying the challenge of transforming data into meaningful information. Processing data can require an increasingly complex ecosystem of customized tools, which increases difficulty in communicating analyses in an understandable way yet is of sufficient detail to enable informed decisions or repeats. This can be of particular interest to institutions and companies communicating computations in a regulatory environment. BioCompute Objects (BCOs; an instance of pipeline documentation that conforms to the IEEE 2791-2020 standard) were developed as a standardized mechanism for analysis reporting. A suite of BCOs is presented, representing interconnected elements of a computation modeled after those that might be found in a regulatory submission but are shared publicly - in this case a pipeline designed to identify viral contaminants in biological manufacturing, such as for vaccines.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006917
003      
CZ-PrNML
005      
20240423155556.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.drudis.2024.103884 $2 doi
035    __
$a (PubMed)38219969
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Keeney, Jonathon G $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA. Electronic address: keeneyjg@gwu.edu
245    10
$a Communicating computational workflows in a regulatory environment / $c JG. Keeney, N. Gulzar, JB. Baker, O. Klempir, GD. Hannigan, DA. Bitton, JM. Maritz, CHS. King, JA. Patel, P. Duncan, R. Mazumder
520    9_
$a The volume of nucleic acid sequence data has exploded recently, amplifying the challenge of transforming data into meaningful information. Processing data can require an increasingly complex ecosystem of customized tools, which increases difficulty in communicating analyses in an understandable way yet is of sufficient detail to enable informed decisions or repeats. This can be of particular interest to institutions and companies communicating computations in a regulatory environment. BioCompute Objects (BCOs; an instance of pipeline documentation that conforms to the IEEE 2791-2020 standard) were developed as a standardized mechanism for analysis reporting. A suite of BCOs is presented, representing interconnected elements of a computation modeled after those that might be found in a regulatory submission but are shared publicly - in this case a pipeline designed to identify viral contaminants in biological manufacturing, such as for vaccines.
650    12
$a výpočetní biologie $7 D019295
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    12
$a vakcíny $7 D014612
650    _2
$a průběh práce $7 D057188
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gulzar, Naila $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
700    1_
$a Baker, Jack B $u Merck & Co., Kenilworth, NJ, USA
700    1_
$a Klempir, Ondrej $u R&D Informatics Solutions, MSD Czech Republic, Prague, Czech Republic
700    1_
$a Hannigan, Geoffrey D $u Exploratory Science Center, Merck & Co., Cambridge, MA, USA
700    1_
$a Bitton, Danny A $u R&D Informatics Solutions, MSD Czech Republic, Prague, Czech Republic
700    1_
$a Maritz, Julia M $u Exploratory Science Center, Merck & Co., Cambridge, MA, USA
700    1_
$a King, Charles H S $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
700    1_
$a Patel, Janisha A $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
700    1_
$a Duncan, Paul $u Merck & Co., Kenilworth, NJ, USA
700    1_
$a Mazumder, Raja $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
773    0_
$w MED00173737 $t Drug discovery today $x 1878-5832 $g Roč. 29, č. 3 (2024), s. 103884
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38219969 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155553 $b ABA008
999    __
$a ok $b bmc $g 2081098 $s 1216684
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 29 $c 3 $d 103884 $e 20240112 $i 1878-5832 $m Drug discovery today $n Drug Discov Today Dis Mech $x MED00173737
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace